Houlihan Lokey Inc
3 nominees · 3 ballot items.
Election of three Class I directors, advisory vote on executive compensation, and ratification of KPMG LLP as independent auditor.
Follow how the vote landed and what changed on Houlihan Lokey Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of three Class I directors to the board (Beiser, Carter, Zuber) with Dr. Kosecoff’s term expiring; board will be reduced to ten directors.
- 2
Advisory Vote on Executive Compensation
ManagementBoard: FORNon-binding advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement.
- 3
Ratification of Independent Auditor
ManagementBoard: FORratification of KPMG LLP as Houlihan Lokey, Inc.’s independent registered public accounting firm for the fiscal year ending March 31, 2026.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.6% | 3,174,853 | $456M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.0% | 2,778,410 | $399M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 2,419,332 | $347M |
| 4 | EARNEST PARTNERS LLC | 3.2% | 2,228,984 | $320M |
| 5 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2.5% | 1,713,248 | $246M |
| 6 | STATE STREET CORP | 2.5% | 1,693,696 | $243M |
| 7 | ROYAL BANK OF CANADA | 2.4% | 1,646,309 | $236M |
| 8 | BlackRock, Inc. | 2.4% | 1,639,154 | $235M |
| 9 | Capital Research Global Investors | 1.9% | 1,314,674 | $189M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 1,146,717 | $165M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Houlihan Lokey Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Houlihan Lokey Inc 2025 annual meeting?
- Houlihan Lokey Inc (HLI) holds its 2025 annual shareholder meeting on Wednesday, September 17, 2025.
- What is the record date for the Houlihan Lokey Inc 2025 meeting?
- The record date for the Houlihan Lokey Inc 2025 meeting is Thursday, July 24, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Houlihan Lokey Inc's 2025 meeting?
- The board is presenting 3 director nominees at the Houlihan Lokey Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Houlihan Lokey Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Houlihan Lokey Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.